Mark Phillips

Mark Phillips is an accomplished healthcare professional with extensive experience in clinical affairs and medical management across various organizations. Currently serving as Chief Clinical Officer and Head of Research and Medical Affairs at Annalise.ai since April 2022, Mark previously held roles at Teva Pharmaceuticals as Medical Director - APAC and Director of Scientific Affairs - ANZ, overseeing Medical Affairs, Regulatory Affairs, and Quality among others. Prior experience includes senior positions at ResMed, leading Global Medical Affairs, and Cochlear, where Mark headed Global Clinical Affairs and Post-Market Surveillance, establishing governance structures for clinical studies. Mark's background also encompasses leadership roles at Medtronic, AllVascular Pty Ltd, and academic positions at Royal North Shore Hospital and UTS. Mark holds a PhD in Vascular Surgery and a BSc (Hons) in Anatomy from the University of Otago.